Debt - IIP Life Science Credit Facility Narrative (Details) - Revolving Facility - Life science credit facility - Line of Credit |
3 Months Ended | ||
|---|---|---|---|
|
Oct. 03, 2025
USD ($)
|
Mar. 31, 2026
USD ($)
|
Dec. 31, 2025
USD ($)
|
|
| Debt Instrument [Line Items] | |||
| Revolving credit facility maximum | $ 100,000,000.0 | ||
| Accordion feature, increase limit | $ 135,000,000.0 | ||
| Variable interest rate | 2.00% | ||
| Loan amount outstanding | $ 75,000,000.0 | $ 75,000,000.0 | |
| Debt service coverage covenant ratio | 2.0 | ||
| Issuance costs | 900,000 | ||
| Amortization of issuance cost | $ 79,000 | ||
| Minimum | |||
| Debt Instrument [Line Items] | |||
| Variable interest rate | 6.10% |
| X | ||||||||||
- Definition Debt Instrument, Covenant, Debt Service Coverage Ratio, Minimum No definition available.
|
| X | ||||||||||
- Definition Line of credit facility, accordion feature, increase limit, subject to certain conditions by obtaining additional commitments from existing and/or new lenders. No definition available.
|
| X | ||||||||||
- Definition Amount of amortization expense attributable to debt issuance costs. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Percentage points added to the reference rate to compute the variable rate on the debt instrument. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount, before accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The carrying value as of the balance sheet date of the noncurrent portion of long-term obligations drawn from a line of credit, which is a bank's commitment to make loans up to a specific amount. Examples of items that might be included in the application of this element may consist of letters of credit, standby letters of credit, and revolving credit arrangements, under which borrowings can be made up to a maximum amount as of any point in time conditional on satisfaction of specified terms before, as of and after the date of drawdowns on the line. Includes short-term obligations that would normally be classified as current liabilities but for which (a) postbalance sheet date issuance of a long term obligation to refinance the short term obligation on a long term basis, or (b) the enterprise has entered into a financing agreement that clearly permits the enterprise to refinance the short-term obligation on a long term basis and the following conditions are met (1) the agreement does not expire within 1 year and is not cancelable by the lender except for violation of an objectively determinable provision, (2) no violation exists at the BS date, and (3) the lender has entered into the financing agreement is expected to be financially capable of honoring the agreement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|